Mianserin: result of a decade of antidepressant research

Abstract

Mianserin is a new tetracyclic compound being the active principle of the antidepressant drug Tolvon®. Originally synthesized as an antiallergic, the discovery of the antidepressant activity of mianserin was serendipitous.

This review describes the historical development of mianserin as the first representative of a second generation of antidepressants. A summary is given of the clinical trials performed leading to a therapeutic profile of an antidepressant of similar efficacy as tricyclic products, however, with fewer and less severe side effects. Unlike tricyclic products mianserin lacks cardiotoxicity resulting in a superior safety also in overdosage.

This is a preview of subscription content, access via your institution.

References

  1. Burg, W. Van Der, I.L. Bonta, J. Delobelle, C. Ramon andB. Vargaftig (1970)J. Med. Chem. 1, 35–39.

    Google Scholar 

  2. Burgess, C.D., S. Montgomery, J. Wadsworth andL. Turner (1979)Postgrad. Med. J. 55, 704–708.

    Google Scholar 

  3. Burrows, G.D., B. Davis, A. Hamer andJ. Vohra (1979)Med. J. Australia II, 97–98.

    Google Scholar 

  4. Carney, M.W.P. (1979)Br. J. Psychiat. 134, 637–639.

    Google Scholar 

  5. Cohen, R.M., I.C. Campbell, M.R. Cohen, T. Torda, D. Pickar, N.J. Siever andD.L. Murphy (1980)Psychiat. Res. 3, 93–105.

    Google Scholar 

  6. Crome, P., andB. Newman (1979)J. R. Soc. Med. 72, 649–653.

    Google Scholar 

  7. Curson, D.A., andA.S. Hale (1979)Br. Med. J. I, 378–379.

    Google Scholar 

  8. Edwards, J.G. (1979)Lancet II, 1368–1369.

    Google Scholar 

  9. Hamouz, W., R.M. Pinder andS.M. Stulemeyer (1980)Pharmakopsychiatr. Neuro-Psychopharmakol. 13, 79–83.

    Google Scholar 

  10. Itil, T.M. (1975) In:The GB94 story.Proceedings of a symposium on depressive illness and experience with a new antidepressant drug GB94 (Vossenaar, T., Ed.). Excerpta Medica, Amsterdam, 9–21.

    Google Scholar 

  11. Itil, T.M., N. Polvan andW. Hsu (1972)Curr. Therap. Res. 14, 395–413.

    Google Scholar 

  12. Mathew, R.J., M. Weinman andJ.L. Claghorn (1980)Psychopharmacol. Bull. 16, 58–60.

    Google Scholar 

  13. Mcharg, A.M., andJ.F. Mcharg (1979)Br. Med. J. 1, 623–624.

    Google Scholar 

  14. Montgomery, S.A. (1980)Curr. Med. Res. Opin. 6, Suppl. 7, 23–28.

    Google Scholar 

  15. Murphy, J.E., J.F. Donald andA.L. Molla (1976)Practitioner 217, 135–138.

    Google Scholar 

  16. Peet, M. (1977)Drugs Exptl. Clin. Res. 1, 363–367.

    Google Scholar 

  17. Perry, G.F., B. Fitzsimmons, L. Shapiro andP. Irwin (1978)Br. J. Clin. Pharmacol, 5, Suppl. 1, 35S-42S.

    Google Scholar 

  18. Pinder, R.M., andM. Fink (1982) In:Modern Problems of Pharmacopsychiatry 18 (Ban, T.A., F.A. Freyhan andW. Pöldinger Eds.). S. Karger, A.G., Basel, 70–101.

    Google Scholar 

  19. Riezen, H. Van, R.M. Pinder, V. Nickolson, P. Hobbelen, F. Vn Der Veen andI. Zayed (1981) In:Pharmacological and biochemical properties of drug substances 3 (Goldberg, M.E., Ed.). American Pharmaceutical Association, Washington, 56–93.

    Google Scholar 

  20. Rodstein M., andL.S. Oei (1979)J. Am. Geriat. Soc. 27, 231–234.

    Google Scholar 

  21. Russell, G.F.M., U. Niaz, A. Wakeling andP.D. Slade (1978)Br. J. Clin. Pharmacol. 5, Suppl. 1, 57S-66S.

    Google Scholar 

  22. Saxena, P.R., P. Van Houwelingen andI.L. Bonta (1971)Eur. J. Pharmac. 13, 295–305.

    Google Scholar 

  23. Segawa, T., T. Mizuta andY. Nomura (1979)Eur. J. Pharmacol. 58, 75–83.

    Google Scholar 

  24. Sulser, F., J. Vetulani andP.L. Mobley (1978)Biochem. Pharmacol. 27, 257–264.

    Google Scholar 

  25. Vargaftig, B.B., J.L. Coignet, C.J. De Vos, H. Grijsen andI.L. Bonta (1971)Eur. J. Pharmac. 16, 336–346.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

De Ridder, J.J. Mianserin: result of a decade of antidepressant research. Pharmaceutisch Weekblad Scientific Edition 4, 139–145 (1982). https://doi.org/10.1007/BF01959033

Download citation

Keywords

  • Public Health
  • Clinical Trial
  • Internal Medicine
  • Historical Development
  • Tricyclic